glp-1 patch safety How to Wear Patches: Current Status and Approved Alternatives How to Use GLP-1 Patches:

Patch test 24 hours prior to full application to assess sensitivity

Actually, its not that unusual

(2017) Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial Janet Vittone, et al

It also underscores the possibility of using MSCs to address the wound and vessel fragility in vascular EDS, though controlled studies are needed

It blocks the responses of the sphincter muscle of the iris and the accommodative muscle of the ciliary body to cholinergic stimulation, producing pupillary dilation (mydriasis) and paralysis of accommodation (cycloplegia)